Peptide Research

FDA Advisory Panel Recommends Allowing Two Unproven Peptides in Pharmacies

If the FDA adopts the panel's advice, pharmacies would be able to legally prepare BPC-157 and KPV even though agency scientists say human safety and efficacy data remain inadequate.